Get started
Author

Tetsuo Nakano

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
2012 · Toshitaka Nakamura, Toshitsugu Sugimoto, et al. · The Journal of Clinical Endocrinology & Metabolism · 268
PDF
Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
2014 · Toshitaka Nakamura, Toshio Matsumoto, et al. · The Journal of Clinical Endocrinology & Metabolism · 173
The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture
2011 · Hiroshi Hagino, Takeshi Sawaguchi, et al. · Calcified Tissue International · 143
Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trial
2006 · Keizo Sakamoto, Toshitaka Nakamura, et al. · Journal of Orthopaedic Science · 94
Predictors for Ambulatory Ability and the Change in ADL After Hip Fracture in Patients With Different Levels of Mobility Before Injury
2011 · Naoshi Fukui, Yoshinobu Watanabe, et al. · Journal of Orthopaedic Trauma · 87
Nationwide one-decade survey of hip fractures in Japan
2010 · Hiroshi Hagino, Keizo Sakamoto, et al. · Journal of Orthopaedic Science · 85
Report on the Japanese Orthopaedic Association’s 3-year project observing hip fractures at fixed-point hospitals
2006 · Keizo Sakamoto, Toshitaka Nakamura, et al. · Journal of Orthopaedic Science · 85
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
2013 · For the MOVER Study Group, Toshitaka Nakamura, et al. · Calcified Tissue International · 59
PDF
Three years of treatment with minodronate in patients with postmenopausal osteoporosis
2011 · Hiroshi Hagino, Masataka Shiraki, et al. · Journal of Bone and Mineral Metabolism · 35
PDF
High prevalence of hypovitaminosis D and K in patients with hip fracture.
2011 · Tetsuo Nakano, Naoko Tsugawa, et al. · PubMed · 32
Retrospective multicenter study of surgical treatments for osteoporotic vertebral fractures
2010 · Manabu Ito, Atsushi Harada, et al. · Journal of Orthopaedic Science · 28
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)
2020 · Toshio Matsumoto, Kazuhiko Yamamoto, et al. · Journal of Bone and Mineral Metabolism · 27
Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial
2013 · Tetsuo Nakano, Masataka Shiraki, et al. · Journal of Bone and Mineral Metabolism · 27
Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial
2012 · Toshitsugu Sugimoto, Masataka Shiraki, et al. · Current Medical Research and Opinion · 26
Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in Japan
2011 · Mayumi Sakuma, Naoto Endo, et al. · Journal of Orthopaedic Science · 26
Nationwide survey of current medical practices for hospitalized elderly with spine fractures in Japan
2010 · Atsushi Harada, Yukihiro Matsuyama, et al. · Journal of Orthopaedic Science · 23
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
2017 · Toshitsugu Sugimoto, Masataka Shiraki, et al. · Advances in Therapy · 20
PDF
Operative Repair of Massive Rotator Cuff Tears.
1999 · Yasuyuki Abe, Tetsuo Nakano, et al. · Orthopedics & Traumatology · 19
PDF
Individual Differences in Compensatory Rebound of Rem Sleep, With Particular Reference to Their Relationship to Personality and Behavioral Characteristics
1975 · YOICHI NAKAZAWA, MAKOTO KOTORII, et al. · The Journal of Nervous and Mental Disease · 18
Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
2013 · Hiroshi Hagino, Masataka Shiraki, et al. · Journal of Bone and Mineral Metabolism · 17
Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial
2016 · Naoto Endo, Keiji Fujino, et al. · Journal of Bone and Mineral Metabolism · 16
Justification criteria for vertebral fractures: year 2012 revision
2013 · Satoshi Mori, Satoshi Soen, et al. · Journal of Bone and Mineral Metabolism · 13
Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study
2015 · Tetsuo Nakano, Masao Yamamoto, et al. · Journal of Bone and Mineral Metabolism · 10
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study
2017 · Hiroshi Hagino, Masako Ito, et al. · Journal of Bone and Mineral Metabolism · 9
Contribution of hypoalbuminemia and decreased renal function to the increased mortality after newly diagnosed vertebral fracture in Japanese subjects.
2016 · Tetsuo Nakano, Akiko Kuwabara, et al. · PubMed · 8
Works count: 108
Citation count: 1,383
H-index: 18
I10-index: 23
Year
Topic
Type